{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:18:15Z","timestamp":1794493095619,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82473769"],"award-info":[{"award-number":["No.82473769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.T2321004"],"award-info":[{"award-number":["No.T2321004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82373921"],"award-info":[{"award-number":["No.82373921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62645-6","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T22:46:58Z","timestamp":1754952418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimization"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhijiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuhan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zean","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-3019","authenticated-orcid":false,"given":"Javier","family":"Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-2214","authenticated-orcid":false,"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-2723","authenticated-orcid":false,"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-9788","authenticated-orcid":false,"given":"Fan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-6026","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"62645_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.berh.2010.10.004","volume":"24","author":"E Smith","year":"2010","unstructured":"Smith, E., Diaz-Torne, C., Perez-Ruiz, F. & March, L. Epidemiology of gout: an update. Best. Pract. Res. Clin. Rheumatol. 24, 811\u2013827 (2010).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"62645_CR2","doi-asserted-by":"publisher","first-page":"12619","DOI":"10.1039\/D2FO02431D","volume":"13","author":"S Lin","year":"2022","unstructured":"Lin, S. et al. Ganoderma lucidum polysaccharide peptide alleviates hyperuricemia by regulating adenosine deaminase and urate transporters. Food Funct. 13, 12619\u201312631 (2022).","journal-title":"Food Funct."},{"key":"62645_CR3","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai, H., Adachi, H., Hakoshima, M. & Katsuyama, H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int. J. Mol. Sci. 22, 9221 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"62645_CR4","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41440-023-01273-3","volume":"46","author":"M Kuwabara","year":"2023","unstructured":"Kuwabara, M. et al. Update in uric acid, hypertension, and cardiovascular diseases. Hypertens. Res. 46, 1714\u20131726 (2023).","journal-title":"Hypertens. Res."},{"key":"62645_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/biom13101519","volume":"13","author":"M Kuwabara","year":"2023","unstructured":"Kuwabara, M. et al. Exploring the multifaceted nexus of uric acid and health: a review of recent studies on diverse diseases. Biomolecules 13, 1519 (2023).","journal-title":"Biomolecules"},{"key":"62645_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2019.01.043","volume":"166","author":"X Li","year":"2019","unstructured":"Li, X., Liu, J., Ma, L. & Fu, P. Pharmacological urate-lowering approaches in chronic kidney disease. Eur. J. Med. Chem. 166, 186\u2013196 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"62645_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jconrel.2023.09.011","volume":"362","author":"X Peng","year":"2023","unstructured":"Peng, X. et al. Gout therapeutics and drug delivery. J. Control Release 362, 728\u2013754 (2023).","journal-title":"J. Control Release"},{"key":"62645_CR8","doi-asserted-by":"publisher","first-page":"107042","DOI":"10.1016\/j.bioorg.2023.107042","volume":"143","author":"N Kumar","year":"2024","unstructured":"Kumar, N., Kaur, K., Kaur, N., Singh, E. & Bedi, P. Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020-2023). Bioorg. Chem. 143, 107042 (2024).","journal-title":"Bioorg. Chem."},{"key":"62645_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","volume":"16","author":"HJ Shin","year":"2011","unstructured":"Shin, H. J. et al. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology 16, 156\u2013162 (2011).","journal-title":"Nephrology"},{"key":"62645_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","volume":"34","author":"Y Dai","year":"2024","unstructured":"Dai, Y. & Lee, C. H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res. 34, 776\u2013787 (2024).","journal-title":"Cell Res"},{"key":"62645_CR11","doi-asserted-by":"publisher","first-page":"e28641","DOI":"10.1371\/journal.pone.0028641","volume":"6","author":"V Tasic","year":"2011","unstructured":"Tasic, V. et al. Clinical and functional characterization of URAT1 variants. PloS one 6, e28641 (2011).","journal-title":"PloS one"},{"key":"62645_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/1759720X16682010","volume":"9","author":"A Waller","year":"2017","unstructured":"Waller, A. & Jordan, K. M. Use of febuxostat in the management of gout in the United Kingdom. Ther. Adv. Musculoskelet. Dis. 9, 55\u201364 (2017).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"62645_CR13","first-page":"CD006077","volume":"2014","author":"R Seth","year":"2014","unstructured":"Seth, R., Kydd, A. S., Buchbinder, R., Bombardier, C. & Edwards, C. J. Allopurinol for chronic gout. Cochrane Database Syst. Rev. 2014, CD006077 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"62645_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","volume":"31","author":"M-HH Lee","year":"2008","unstructured":"Lee, M.-H. H., Graham, G. G., Williams, K. M. & Day, R. O. A benefit-risk assessment of benzbromarone in the treatment of gout: was its withdrawal from the market in the best interest of patients? Drug Saf. 31, 643\u2013665 (2008).","journal-title":"Drug Saf."},{"key":"62645_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0906-9","volume":"18","author":"JN Miner","year":"2016","unstructured":"Miner, J. N. et al. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Arthritis Res. Ther. 18, 1\u201310 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"62645_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40266-017-0461-y","volume":"34","author":"ED Deeks","year":"2017","unstructured":"Deeks, E. D. Lesinurad: a review in hyperuricaemia of gout. Drugs Aging 34, 401\u2013410 (2017).","journal-title":"Drugs Aging"},{"key":"62645_CR17","doi-asserted-by":"publisher","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","volume":"14","author":"YR Liu","year":"2013","unstructured":"Liu, Y. R., Wang, J. Q. & Li, J. Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front. Immunol. 14, 1137822 (2013).","journal-title":"Front. Immunol."},{"key":"62645_CR18","doi-asserted-by":"publisher","first-page":"117874","DOI":"10.1016\/j.bmc.2024.117874","volume":"112","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors. Bioorg. Med. Chem. 112, 117874 (2024).","journal-title":"Bioorg. Med. Chem."},{"key":"62645_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll, R. C. et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat. Chem. Biol. 15, 556\u2013559 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"62645_CR20","first-page":"195","volume":"22","author":"Z Luo","year":"2024","unstructured":"Luo, Z., Yin, F., Wang, X. & Kong, L. Progress in approved drugs from natural product resources. Chin. J. Nat. Med. 22, 195\u2013211 (2024).","journal-title":"Chin. J. Nat. Med."},{"key":"62645_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11418-020-01433-6","volume":"74","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Anti-inflammatory canthin-6-one alkaloids from the roots of Thailand Eurycoma longifolia Jack. J. Nat. Med. 74, 804\u2013810 (2020).","journal-title":"J. Nat. Med."},{"key":"62645_CR22","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.3390\/molecules27144398","volume":"27","author":"G Ye","year":"2022","unstructured":"Ye, G. et al. A quassinoid diterpenoid Eurycomanone from Eurycoma longifolia Jack exerts anti-cancer effect through autophagy inhibition. Molecules 27, 4398 (2022).","journal-title":"Molecules"},{"key":"62645_CR23","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3390\/nu12072111","volume":"12","author":"CH Tsai","year":"2020","unstructured":"Tsai, C. H. et al. The powdered root of Eurycoma longifolia Jack improves beta-cell number and pancreatic islet performance through Pdx1 induction and shows antihyperglycemic activity in db\/db mice. Nutrients 12, 2111 (2020).","journal-title":"Nutrients"},{"key":"62645_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/molecules21030331","volume":"21","author":"SU Rehman","year":"2016","unstructured":"Rehman, S. U., Choe, K. & Yoo, H. H. Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules 21, 331 (2016).","journal-title":"Molecules"},{"key":"62645_CR25","first-page":"224","volume":"21","author":"L Peng","year":"2018","unstructured":"Peng, L. et al. Experimental study on the anti-hyperuricemia effect of different extracts of Tongkat Ali. China Pharm. 21, 224\u2013227 (2018).","journal-title":"China Pharm."},{"key":"62645_CR26","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3389\/fphar.2019.01464","volume":"10","author":"R Bao","year":"2019","unstructured":"Bao, R. et al. Effect of eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice. Front. Pharmacol. 10, 1464 (2019).","journal-title":"Front. Pharmacol."},{"key":"62645_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153850","volume":"96","author":"R Bao","year":"2022","unstructured":"Bao, R. et al. Eurycomanol alleviates hyperuricemia by promoting uric acid excretion and reducing purine synthesis. Phytomedicine 96, 153850 (2022).","journal-title":"Phytomedicine"},{"key":"62645_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"JG Moffat","year":"2017","unstructured":"Moffat, J. G., Vincent, F., Lee, J. A., Eder, J. & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat. Rev. Drug Discov. 16, 531\u2013543 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62645_CR29","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.drup.2024.101077","volume":"74","author":"F Wang","year":"2024","unstructured":"Wang, F. et al. A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer. Drug Resist Updat. 74, 101077 (2024).","journal-title":"Drug Resist Updat."},{"key":"62645_CR30","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.bioorg.2019.103302","volume":"92","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Lai, L., Ju, Y., Liu, C. & Meng, D. Chemical constituents and synergistic anti-gout studies on Eurycoma longifolia and potential mechanisms evaluation based on systemic analysis approach. Bioorg. Chem. 92, 103302 (2019).","journal-title":"Bioorg. Chem."},{"key":"62645_CR31","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","volume":"63","author":"T Zhao","year":"2020","unstructured":"Zhao, T. et al. Novel human urate transporter 1 inhibitors as hypouricemic drug candidates with favorable druggability. J. Med. Chem. 63, 10829\u201310854 (2020).","journal-title":"J. Med. Chem."},{"key":"62645_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","volume":"604","author":"IV Hochheiser","year":"2022","unstructured":"Hochheiser, I. V. et al. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604, 184\u2013189 (2022).","journal-title":"Nature"},{"key":"62645_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MS Mangan","year":"2018","unstructured":"Mangan, M. S. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588\u2013606 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62645_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167309","volume":"433","author":"C Dekker","year":"2021","unstructured":"Dekker, C. et al. Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition. J. Mol. Biol. 433, 167309 (2021).","journal-title":"J. Mol. Biol."},{"key":"62645_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/13543776.2022.2165911","volume":"32","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020\u2013present). Expert Opin. Ther. Pat. 32, 1175\u20131184 (2022).","journal-title":"Expert Opin. Ther. Pat."},{"key":"62645_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41421-025-00779-z","volume":"11","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs. Cell Discov. 11, 33 (2025).","journal-title":"Cell Discov."},{"key":"62645_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10408347.2014.881250","volume":"45","author":"A Olaru","year":"2015","unstructured":"Olaru, A., Bala, C., Jaffrezic-Renault, N. & Aboul-Enein, H. Y. Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. Crit. Rev. Anal. Chem. 45, 97\u2013105 (2015).","journal-title":"Crit. Rev. Anal. Chem."},{"key":"62645_CR38","doi-asserted-by":"publisher","first-page":"115784","DOI":"10.1016\/j.ejmech.2023.115784","volume":"260","author":"C Shi","year":"2023","unstructured":"Shi, C. et al. Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases. Eur. J. Med. Chem. 260, 115784 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"62645_CR39","doi-asserted-by":"publisher","first-page":"F612","DOI":"10.1152\/ajprenal.00139.2009","volume":"297","author":"S Bibert","year":"2009","unstructured":"Bibert, S. et al. Mouse GLUT9: evidences for a urate uniporter. Am. J. Physiol. Ren. Physiol. 297, F612\u2013F619 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"62645_CR40","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/ndt\/gfn349","volume":"23","author":"MT Le","year":"2008","unstructured":"Le, M. T., Shafiu, M., Mu, W. & Johnson, R. J. SLC2A9\u2014a fructose transporter identified as a novel uric acid transporter. Nephrol. Dial. Transplant. 23, 2746\u20132749 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"62645_CR41","doi-asserted-by":"publisher","first-page":"1026246","DOI":"10.3389\/fphar.2022.1026246","volume":"13","author":"B Yang","year":"2022","unstructured":"Yang, B. et al. New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds. Front. Pharmacol. 13, 1026246 (2022).","journal-title":"Front. Pharmacol."},{"key":"62645_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1152\/physrev.00025.2013","volume":"95","author":"SK Nigam","year":"2015","unstructured":"Nigam, S. K. et al. The organic anion transporter (OAT) family: a systems biology perspective. Physiol. Rev. 95, 83\u2013123 (2015).","journal-title":"Physiol. Rev."},{"key":"62645_CR43","unstructured":"Chai Discovery team, et al. Chai-1: decoding the molecular interactions of life. BioRxiv. (2024)."},{"key":"62645_CR44","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1021\/acs.jmedchem.1c02057","volume":"65","author":"T Zhao","year":"2022","unstructured":"Zhao, T. et al. Discovery of novel bicyclic imidazolopyridine-containing human urate transporter 1 inhibitors as hypouricemic drug candidates with improved efficacy and favorable druggability. J. Med. Chem. 65, 4218\u20134237 (2022).","journal-title":"J. Med. Chem."},{"key":"62645_CR45","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s11255-020-02754-x","volume":"53","author":"F Li","year":"2021","unstructured":"Li, F. et al. Clinical classification of hyperuricemia in patients with chronic kidney disease. Int Urol. Nephrol. 53, 1665\u20131674 (2021).","journal-title":"Int Urol. Nephrol."},{"key":"62645_CR46","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So, A. & Thorens, B. Uric acid transport and disease. J. Clin. Invest. 120, 1791\u20131799 (2010).","journal-title":"J. Clin. Invest."},{"key":"62645_CR47","doi-asserted-by":"crossref","unstructured":"Bowers, K. J. et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proc. ACM\/IEEE Conference on Supercomputing (SC06), 11-17 (IEEE, 2006).","DOI":"10.1145\/1188455.1188544"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:26:44Z","timestamp":1757377604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62645"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62645-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7430"}}